Skip to main content
logo
BioMarin Pharmaceutical Inc. (BIT:1BMRN)
Italy flag Italy · Delayed Price · Currency is EUR
44.72
-1.93 (-4.14%)
At close: Oct 10, 2025

Revenue

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 20212011 - 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 2011 - 2020
VOXZOGO Revenue
833.43M735.09M
Log In
Log In
Log In
Upgrade
VIMIZIM Revenue
773.02M739.78M
Log In
Log In
Log In
Upgrade
NAGLAZYME Revenue
485.06M479.58M
Log In
Log In
Log In
Upgrade
PALYNZIQ Revenue
390.25M355.05M
Log In
Log In
Log In
Upgrade
ALDURAZYME Revenue
215.48M183.89M
Log In
Log In
Log In
Upgrade
BRINEURA Revenue
173.78M169.08M
Log In
Log In
Log In
Upgrade
KUVAN Revenue
108.61M120.90M
Log In
Log In
Log In
Upgrade
ROCTAVIAN Revenue
37.49M26.07M
Log In
Log In
Log In
Upgrade
Total Net Product Revenue
3.02B2.81B
Log In
Log In
Log In
Upgrade
Royalty and Other Revenue
46.48M44.47M
Log In
Log In
Log In
Upgrade
Revenue (Other)
-37.49M-26.07M
Log In
Log In
Log In
Upgrade
Revenue (Total)
3.06B2.85B
Log In
Log In
Log In
Upgrade

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 20212011 - 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 2011 - 2020
Royalty and Other Revenue
46.48M44.47M
Log In
Log In
Log In
Upgrade
United States Revenue
1.02B924.81M
Log In
Log In
Log In
Upgrade
Europe Revenue
885.01M829.03M
Log In
Log In
Log In
Upgrade
Latin America Revenue
401.47M378.08M
Log In
Log In
Log In
Upgrade
Rest of World Revenue (Pre-Q3 2024)
--
Log In
Log In
Log In
Upgrade
Rest of World Revenue (Post-Q2 2024)
496.56M493.63M
Log In
Log In
Log In
Upgrade
Revenue (Other)
215.48M183.89M
Log In
Log In
Log In
Upgrade
Revenue (Total)
3.06B2.85B
Log In
Log In
Log In
Upgrade
Updated Jun 30, 2025. Data Source: Fiscal.ai.